Main navigation
Search Results
-
Event - - Berlin, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/smith-congress-2022 -
Press release - 03/06/2022 Deep Learning helps improve gene therapies and antiviral drugs
The nuclease Cas13b associated with the CRISPR gene scissors, which is an enzyme that degrades nucleic acids, has the potential to be used in the future in hereditary diseases to switch off unwanted genes. In the fight against infections, this nuclease is also being researched as an antiviral agent, as Cas13b can specifically intervene in the genetic material of viruses and render them harmless.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/deep-learning-helps-improve-gene-therapies-and-antiviral-drugs -
Press release - 02/06/2022 Groundbreaking ceremony for new research building on the Faculty of Engineering campus
Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Tourism of Baden-Württemberg, together with Freiburg’s Mayor Martin Horn, gives the go-ahead for the construction project on the Georges-Köhler-Allee.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/groundbreaking-ceremony-new-research-building-faculty-engineering-campus -
Bakteriocins - 24/05/2022 New antibiotic alternatives from soil bacteria
Bacteria are not the greatest of friends among themselves: many release antimicrobial substances into their environment in order to gain an advantage in their ecological niche. Researchers at the University of Ulm are making use of such bacteriocins by creating a genetically modified soil bacterium that can be used as a biotechnological platform organism to produce alternatives to antibiotics in pure form and in large quantities. The fact this…
https://www.gesundheitsindustrie-bw.de/en/article/news/new-antibiotic-alternatives-soil-bacteria -
Lentil cultivation in a producers’ association - EIP-AGRI Rhizo-Linse project - 23/05/2022 From cultivation to market – lentils from the Swabian Alb
Complicated cultivation, fluctuating yields and complex cleaning: Leisa – as lentils are called in Swabian – are demanding. So to produce lentils economically, 130 farmers in the Swabian Alb have joined forces and set up the organic producers’ association Alb-Leisa. Their lentil harvests are processed and marketed by a company called Lauteracher Alb-Feld-Früchte.
https://www.biooekonomie-bw.de/en/articles/news/cultivation-market-lentils-swabian-alb -
Press release - 20/05/2022 RoofKIT: How to Build in a Recycling-Oriented and Sustainable Way
The construction industry consumes large amounts of energy resources and produces tons of waste. At the Solar Decathlon Europe 21/22 university competition, students and researchers from KIT are eager to demonstrate that the building sector is already compatible with a functioning circular economy. The task of the interdisciplinary “RoofKIT” team is to convert previously unused roofs of buildings into usable spaces.
https://www.biooekonomie-bw.de/en/articles/pm/roofkit-how-build-recycling-oriented-and-sustainable-way -
Press release - 12/05/2022 New imaging method makes tiny medical robots visible in the body
Microrobots have the potential to revolutionize medicine. Researchers at the Max Planck ETH Centre for Learning Systems have now developed an imaging technique that for the first time recognises cell-sized microrobots individually and at high resolution in a living organism. This is an important step towards precise control of the robots and their clinical translation.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-imaging-method-makes-tiny-medical-robots-visible-body -
Press release - 12/05/2022 New hope for broad spectrum viral entry inhibitors – Negatively charged polymer proves effective against a wide range of viruses
While broad-spectrum antibiotics can offer protection against a wide variety of bacteria, there are currently no analogous clinically available broad-spectrum antiviral agents that can act on several different viruses. An international research team has now shown that polystyrene sulfonate (PSS), a negatively charged polymer, has the potential to be used in the prevention of viral infections – not only in the fight against the SARS-CoV-2 and cold…
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-hope-broad-spectrum-viral-entry-inhibitors-negatively-charged-polymer-proves-effective-against-wide-range-viruses -
Product testing under real conditions - 11/05/2022 INSPIRE Living Lab: a bridge between industry and the clinic
Coming up with innovative ideas and products in the medical care area is highly relevant not only for the further development of Baden-Württemberg as a health region, but also for improving healthcare itself. However, bridging the gap between industry and the clinic often proves difficult. To drive this process forward, the INSPIRE Living Lab was opened at the University Medical Centre Mannheim in 2021.
https://www.gesundheitsindustrie-bw.de/en/article/news/inspire-living-lab-bridge-between-industry-and-clinic -
Mini-factories for producing bioplastics - 05/05/2022 Bacteria produce bioplastics: resource-saving and very environmentally friendly
Using living cells as mini-factories to produce plastic from nothing more than water, sunlight and carbon dioxide; plastic that is also 100 percent degradable – it sounds far-fetched but it actually works: researchers at the University of Tübingen have genetically engineered cyanobacteria so that they fill their cells to the brim with polyhydroxybutyrate. The researchers are now turning the idea into reality with the development of pilot plants.
https://www.biooekonomie-bw.de/en/articles/news/bacteria-produce-bioplastics-resource-saving-and-very-environmentally-friendly -
Company profile: medicalvalues GmbH - 05/05/2022 medicalvalues – best possible diagnostics thanks to AI
The Karlsruhe-based start-up medicalvalues GmbH wants to use its platform to bring together different clinical data sets and thus enable comprehensive medical diagnostics. Artificial intelligence featuring innovative diagnostic algorithms is used to evaluate the data and generate new insights for laboratories and hospitals.
https://www.gesundheitsindustrie-bw.de/en/article/news/medicalvalues-best-possible-diagnostics-thanks-ai -
Press release - 28/04/2022 Tumors on withdrawal: Amino acid deficiency shrinks childhood tumors
Certain childhood tumors have an extreme need for amino acids. Scientists at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the University of Heidelberg, and HI-STEM* gGmbH have now discovered the molecular mechanisms underlying this and how the cancer cells could be turned off.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/tumors-withdrawal-amino-acid-deficiency-shrinks-childhood-tumors -
Lentil cleaning - EIP-AGRI Rhizo-Linse project - 26/04/2022 Lentil cleaning in the Altdorf mill
The Altdorf mill, just under 7 km south of the city of Böblingen, has operated lentil cleaning facilities since 2019, the year that the Sessler mill in Renningen, 20 km further north, ceased all operations including lentil cleaning. After receiving a number of enquiries from farmers and local mills, brothers Karl and Jörg Ruthardt took a chance and launched a lentil cleaning operation in addition to their mill and farm shop business.
https://www.biooekonomie-bw.de/en/articles/news/lentil-cleaning-altdorf-mill -
Press release - 25/04/2022 Reprogrammed macrophages promote spread of breast cancer
Metastatic breast cancer cells abuse macrophages, a type of immune cell, to promote the settlement of cancer metastases in the lungs. The reprogrammed macrophages stimulate blood vessel cells to secrete a cocktail of metastasis-promoting proteins that are part of the so-called metastatic niche.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/reprogrammed-macrophages-promote-spread-breast-cancer -
Peptide-based COVID-19 vaccine - 21/04/2022 CoVac-1: T-cell activator against COVID-19
Current vaccines against COVID-19 aim at forming neutralising antibodies that prevent the virus from penetrating the host cells. Since people with impaired B-cell immune responses – which can also occur in cancer or autoimmune diseases – are not able to do this, researchers at the University of Tübingen have developed the peptide-based T-cell activator CoVac-1, which promises broad and long-term immunity.
https://www.gesundheitsindustrie-bw.de/en/article/news/covac-1-t-cell-activator-against-covid-19 -
ProteinDistillery GmbH - 20/04/2022 Using microorganisms to create a source of sustainable protein
Yeast has been part of the human diet for thousands of years. ProteinDistillery GmbH now wants to revolutionise the environmentally friendly protein suppliers market by introducing brewer's yeast and secure the protein supply of the future.
https://www.biooekonomie-bw.de/en/articles/news/using-microorganisms-create-source-sustainable-protein -
pre-start-up company Wheyfinery - 13/04/2022 Acid whey as a valuable raw material for platform chemicals and more
There is not much you can do with acid whey, which is why several million litres of it are disposed of every year. This is both costly and not sustainable. However, researchers at Tübingen University have shown: acid whey can be used to produce precursors for biofuels, fine chemicals and antimicrobial livestock feed additives. They have set up the pre-start-up company Wheyfinery in an endeavour to make their scalable biorefinery concept…
https://www.biooekonomie-bw.de/en/articles/news/acid-whey-valuable-raw-material-platform-chemicals-and-more -
Press release - 13/04/2022 Emmy Noether funding for research into drug resistance of blood cancer
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is funding a new Emmy Noether junior research group at the DKFZ for six years with a total of around 2 million euros. The scientists and doctors, who are part of the Clinical Cooperation Unit for Pediatric Leukemia at the KiTZ, are using a new procedure to investigate how cancer cells manipulate the formation of proteins to become resistant to cancer drugs.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/emmy-noether-funding-research-drug-resistance-blood-cancer -
Press release - 12/04/2022 Technology transfer award for PCR rapid test device for infection diagnostics
Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/technology-transfer-award-pcr-rapid-test-device-infection-diagnostics -
COVIC-19 clinical trial - 07/04/2022 Convalescent plasma for COVID-19 therapy: clinical trial should bring clarity
Does it help to treat COVID-19 sufferers with antibodies from people who have recovered from the disease? It seems an obvious idea and has been tested thousands of times. However, there is not yet enough evidence to prove the clinical efficacy of treating COVID-19 patients with convalescent plasma. The transfusion physician Prof. Dr. Hubert Schrezenmeier from Ulm is planning to carry out a follow-up clinical trial to find the missing evidence.
https://www.gesundheitsindustrie-bw.de/en/article/news/convalescent-plasma-covid-19-therapy-clinical-trial-should-bring-clarity -
Press release - 06/04/2022 High-tech bridge built with flax
The University of Stuttgart is contributing to innovations for climate protection as part of the EU project "Smart Circular Bridge". An old material is being rediscovered: flax has been with us for thousands of years in the form of clothing, sacks, and robust ship's ropes. Now the plant fibres are experiencing a renaissance and could become the building material of the future.
https://www.biooekonomie-bw.de/en/articles/pm/high-tech-bruecke-mit-flachs-gebaut -
Filament winding technology for sustainable construction - 06/04/2022 Robotic building with natural fibres
One of the greatest challenges in the construction industry is the transition to more environmentally friendly and resource-saving buildings. Researchers at the University of Stuttgart are combining state-of-the-art robotic filament winding technologies with ancient local crops to produce stable and sustainable lightweight structures from flax fibres.
https://www.biooekonomie-bw.de/en/articles/news/robotic-building-natural-fibres -
Press release - 06/04/2022 Giant grass miscanthus: Bioethanol source with negative CO2 balance
European collaborative project led by the University of Hohenheim shows: Combining bioethanol production with carbon storage can effectively reduce CO2.
https://www.biooekonomie-bw.de/en/articles/pm/giant-grass-miscanthus-bioethanol-source-negative-co2-balance -
Funding NextGenMicrofluidics
Funding programme, Funded by: JOSNNEUM RESEARCH Forschungsgesellschaft mbH, sb_search.searchresult.label.programSubmissionDate: 30/09/2023https://www.bio-pro.de/en/service/funding/nextgenmicrofluidics-1 -
Press release - 01/04/2022 FDA approval for targeted radioligand therapy for treatment of metastatic prostate cancer
On March 23, 2022, the U.S. Food and Drug Administration (FDA) granted approval to the first targeted radioligand therapy against metastatic prostate cancer based on a joint patent of the German Cancer Research Center (DKFZ) and the University of Heidelberg. The agent significantly improves the chances of survival for those affected.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/fda-approval-targeted-radioligand-therapy-treatment-metastatic-prostate-cancer